US Stock MarketDetailed Quotes

PMCB PharmaCyte Biotech

Watchlist
  • 1.640
  • 0.0000.00%
Close Dec 20 16:00 ET
11.43MMarket Cap1.86P/E (TTM)

PharmaCyte Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Oct 31, 2024
(Q1)Jul 31, 2024
(FY)Apr 30, 2024
(Q4)Apr 30, 2024
(Q3)Jan 31, 2024
(Q2)Oct 31, 2023
(Q1)Jul 31, 2023
(FY)Apr 30, 2023
(Q4)Apr 30, 2023
(Q3)Jan 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
46.85%-1.05M
-208.85%-373.3K
43.29%-2.15M
-15.45%-332.96K
67.31%-177.1K
-5.59%-1.98M
131.63%342.96K
7.86%-3.79M
75.80%-288.39K
-81.39%-541.7K
Net income from continuing operations
-152.67%-1.47M
835.76%23.42M
107.73%333.76K
1,165.95%1.35M
18.92%-619.54K
248.36%2.79M
-106.04%-3.18M
-1.81%-4.32M
91.12%-126.34K
5.81%-764.14K
Operating gains losses
6.68%-3.09M
-1,269.21%-23.17M
---4.17M
---2.62M
---230K
---3.31M
--1.98M
----
----
----
Other non cash items
----
----
-212.05%-195K
----
----
----
40,007.11%913.64K
399.40%174.02K
91.21%5.88K
6,692.30%165.87K
Change In working capital
18.98%-449.33K
-80.07%125.67K
200.58%298.89K
151.90%87.15K
123.67%135.74K
-7,954.17%-554.61K
39.82%630.62K
-3,387.23%-297.17K
-175.60%-167.93K
-215.94%-573.37K
-Change in prepaid assets
-7.87%-252.99K
2.85%19.57K
-1,026.06%-152.12K
-48.23%37.96K
-66.46%25.43K
-2.57%-234.54K
-71.18%19.03K
35.80%-13.51K
-8.26%73.33K
11.97%75.8K
-Change in payables and accrued expense
38.66%-196.34K
-82.65%106.1K
259.00%451.01K
120.39%49.19K
116.99%110.31K
-244.32%-320.07K
58.86%611.59K
-1,033.17%-283.66K
-269.66%-241.25K
-252.08%-649.17K
Cash from discontinued investing activities
Operating cash flow
46.85%-1.05M
-208.85%-373.3K
43.29%-2.15M
-15.45%-332.96K
67.31%-177.1K
-5.59%-1.98M
131.63%342.96K
7.86%-3.79M
75.80%-288.39K
-81.39%-541.7K
Investing cash flow
Cash flow from continuing investing activities
0
-7M
-5M
0
-5M
0
0
0
0
Net investment purchase and sale
--0
---7M
---5M
--0
---5M
--0
--0
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
--0
---7M
---5M
--0
---5M
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
-1,534.56%-10.74M
-261.99%-10.17M
21.03%-10.71M
-148.38%-10.7M
-86.31%-7.04M
122.12%748.69K
400.44%6.28M
-115.53%-13.56M
-8,376.76%-4.31M
-3.78M
Net common stock issuance
-750.87%-1.4M
97.19%-742.18K
-107.94%-28.2M
72.73%-1.17M
89.39%-400.71K
95.13%-164.95K
-1,165.39%-26.46M
-115.52%-13.56M
-113.60%-4.31M
---3.78M
Net preferred stock issuance
-591.66%-9.34M
-126.94%-9.43M
--17.49M
---9.52M
---6.64M
---1.35M
--35M
--0
--0
--0
Proceeds from stock option exercised by employees
--0
--0
-92.05%70
--0
--0
--0
-92.05%70
--880
--0
--0
Net other financing activities
----
----
----
----
----
----
---2.26M
----
----
----
Cash from discontinued financing activities
Financing cash flow
-1,534.56%-10.74M
-261.99%-10.17M
21.03%-10.71M
-148.38%-10.7M
-86.31%-7.04M
122.12%748.69K
400.44%6.28M
-115.53%-13.56M
-8,376.76%-4.31M
---3.78M
Net cash flow
Beginning cash position
-56.29%32.64M
-26.25%50.18M
-20.33%68.04M
-15.73%61.21M
-4.60%73.43M
-9.20%74.66M
-20.33%68.04M
3,778.14%85.4M
-16.16%72.64M
-11.47%76.96M
Current changes in cash
-854.55%-11.8M
-364.95%-17.55M
-2.92%-17.86M
-140.04%-11.03M
-182.79%-12.22M
76.53%-1.24M
308.61%6.62M
-120.86%-17.35M
-269.78%-4.6M
-1,346.47%-4.32M
Effect of exchange rate changes
103.83%61
-59.42%183
92.99%-508
91.70%-438
141.90%1.07K
-120.97%-1.59K
-65.41%451
-256.67%-7.25K
-248.87%-5.28K
-1,116.19%-2.55K
End cash Position
-71.62%20.84M
-56.29%32.64M
-26.25%50.18M
-26.25%50.18M
-15.73%61.21M
-4.60%73.43M
-9.20%74.66M
-20.33%68.04M
-20.33%68.04M
-16.16%72.64M
Free cash flow
46.85%-1.05M
-208.85%-373.3K
43.29%-2.15M
-15.45%-332.96K
67.31%-177.1K
-5.59%-1.98M
131.63%342.96K
7.86%-3.79M
75.80%-288.39K
-81.39%-541.7K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Oct 31, 2024(Q1)Jul 31, 2024(FY)Apr 30, 2024(Q4)Apr 30, 2024(Q3)Jan 31, 2024(Q2)Oct 31, 2023(Q1)Jul 31, 2023(FY)Apr 30, 2023(Q4)Apr 30, 2023(Q3)Jan 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 46.85%-1.05M-208.85%-373.3K43.29%-2.15M-15.45%-332.96K67.31%-177.1K-5.59%-1.98M131.63%342.96K7.86%-3.79M75.80%-288.39K-81.39%-541.7K
Net income from continuing operations -152.67%-1.47M835.76%23.42M107.73%333.76K1,165.95%1.35M18.92%-619.54K248.36%2.79M-106.04%-3.18M-1.81%-4.32M91.12%-126.34K5.81%-764.14K
Operating gains losses 6.68%-3.09M-1,269.21%-23.17M---4.17M---2.62M---230K---3.31M--1.98M------------
Other non cash items ---------212.05%-195K------------40,007.11%913.64K399.40%174.02K91.21%5.88K6,692.30%165.87K
Change In working capital 18.98%-449.33K-80.07%125.67K200.58%298.89K151.90%87.15K123.67%135.74K-7,954.17%-554.61K39.82%630.62K-3,387.23%-297.17K-175.60%-167.93K-215.94%-573.37K
-Change in prepaid assets -7.87%-252.99K2.85%19.57K-1,026.06%-152.12K-48.23%37.96K-66.46%25.43K-2.57%-234.54K-71.18%19.03K35.80%-13.51K-8.26%73.33K11.97%75.8K
-Change in payables and accrued expense 38.66%-196.34K-82.65%106.1K259.00%451.01K120.39%49.19K116.99%110.31K-244.32%-320.07K58.86%611.59K-1,033.17%-283.66K-269.66%-241.25K-252.08%-649.17K
Cash from discontinued investing activities
Operating cash flow 46.85%-1.05M-208.85%-373.3K43.29%-2.15M-15.45%-332.96K67.31%-177.1K-5.59%-1.98M131.63%342.96K7.86%-3.79M75.80%-288.39K-81.39%-541.7K
Investing cash flow
Cash flow from continuing investing activities 0-7M-5M0-5M0000
Net investment purchase and sale --0---7M---5M--0---5M--0--0--0--0----
Cash from discontinued investing activities
Investing cash flow --0---7M---5M--0---5M--0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities -1,534.56%-10.74M-261.99%-10.17M21.03%-10.71M-148.38%-10.7M-86.31%-7.04M122.12%748.69K400.44%6.28M-115.53%-13.56M-8,376.76%-4.31M-3.78M
Net common stock issuance -750.87%-1.4M97.19%-742.18K-107.94%-28.2M72.73%-1.17M89.39%-400.71K95.13%-164.95K-1,165.39%-26.46M-115.52%-13.56M-113.60%-4.31M---3.78M
Net preferred stock issuance -591.66%-9.34M-126.94%-9.43M--17.49M---9.52M---6.64M---1.35M--35M--0--0--0
Proceeds from stock option exercised by employees --0--0-92.05%70--0--0--0-92.05%70--880--0--0
Net other financing activities ---------------------------2.26M------------
Cash from discontinued financing activities
Financing cash flow -1,534.56%-10.74M-261.99%-10.17M21.03%-10.71M-148.38%-10.7M-86.31%-7.04M122.12%748.69K400.44%6.28M-115.53%-13.56M-8,376.76%-4.31M---3.78M
Net cash flow
Beginning cash position -56.29%32.64M-26.25%50.18M-20.33%68.04M-15.73%61.21M-4.60%73.43M-9.20%74.66M-20.33%68.04M3,778.14%85.4M-16.16%72.64M-11.47%76.96M
Current changes in cash -854.55%-11.8M-364.95%-17.55M-2.92%-17.86M-140.04%-11.03M-182.79%-12.22M76.53%-1.24M308.61%6.62M-120.86%-17.35M-269.78%-4.6M-1,346.47%-4.32M
Effect of exchange rate changes 103.83%61-59.42%18392.99%-50891.70%-438141.90%1.07K-120.97%-1.59K-65.41%451-256.67%-7.25K-248.87%-5.28K-1,116.19%-2.55K
End cash Position -71.62%20.84M-56.29%32.64M-26.25%50.18M-26.25%50.18M-15.73%61.21M-4.60%73.43M-9.20%74.66M-20.33%68.04M-20.33%68.04M-16.16%72.64M
Free cash flow 46.85%-1.05M-208.85%-373.3K43.29%-2.15M-15.45%-332.96K67.31%-177.1K-5.59%-1.98M131.63%342.96K7.86%-3.79M75.80%-288.39K-81.39%-541.7K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Ermenegildo Zegna NV
ZGN
+6.16%
DexCom
DXCM
+5.57%
New Fortress Energy
NFE
+5.37%
Workday
WDAY
+2.33%
eBay
EBAY
+1.66%

Unlock the Full List